Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice

被引:19
作者
Chen, ZY
Li, K
Rowland, RRR
Plagemann, PGW
机构
[1] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA
[2] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA
关键词
neutralizing antibody; LDV; paralytic disease;
D O I
10.3109/13550289909022003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neuropathogenic lactate dehydrogenase-elevating viruses (LDV) cytocidally infect anterior horn neurons in C58 and AKR mice via interaction with endogenous murine retroviruses to cause a paralytic disease; age-dependent poliomyelitis (ADPM). The induction of ADPM requires a suppressed host immune system as a result of old age, genetic defects (such as nude mice) or any immunosuppressive treatment. Previous results have shown that the infection of anterior horn neurons by neuropathogenic LDV isolates and the subsequent development of ADPM are prevented by anti-LDV antibodies either induced actively during infection or when passively administered. However, the mechanism of protection was unclear since both neutralizing and nonneutralizing polyclonal antibodies seemed protective, whereas only neutralizing monoclonal antibodies were protective. Furthermore, the protection of motor neurons from infection occurred in the absence of any apparent effect on LDV replication in a subpopulation of macrophages known to be the primary permissive host cells. These paradoxes have now been resolved. We have recently reported that the neuropathogenic LDV isolates contain both neuropathogenic and non-neuropathogenic quasispecies that differ in their ability to establish a high viremia persistent infection. Using biological clones of both neuropathogenic and non-neuropathogenic quasispecies; we now demonstrate that both replicate in the same subpopulation of permissive macrophages, but that the neuropathogenic quasispecies are about 100 times more susceptible to in vitro antibody neutralization than the non-neuropathogenic ones, and that antibodies that neutralize the neuropathogenic but not the non-neuropathogenic quasispecies develop as soon as 7 days after infection with neuropathogenic LDVs and selectively suppress the replication of the neuropathogenic LDVs in vivo in FVB, BALB/c, C57 BL/6 and C58 mice. The previously observed lack of neutralizing effect of early polyclonal anti-LDV antibodies and the apparent ineffective antibody control of LDV replication in macrophages were due to outgrowth of the non-neuropathogenic quasispecies that are also present in the neuropathogenic LDV inoculum and are highly resistant to antibody neutralization. Using cloned neuropathogenic LDV quasispecies, we demonstrate a clear relationship in the development of neutralizing antibodies, replication suppression of the neuropathogenic LDVs and the prevention of ADPM in C58 mice. Our results therefore establish an inseparable relationship between the neuron-protective effect of an antibody and its neutralization of the neuropathogenic LDV quasispecies and explain why neuropathogenic LDVs cause paralytic disease only in immunosuppressed mice.
引用
收藏
页码:200 / 208
页数:9
相关论文
共 28 条
[1]   C58 AND AKR MICE OF ALL AGES DEVELOP MOTOR-NEURON DISEASE AFTER LACTATE DEHYDROGENASE-ELEVATING VIRUS-INFECTION BUT ONLY IF ANTIVIRAL IMMUNE-RESPONSES ARE BLOCKED BY CHEMICAL OR GENETIC MEANS OR AS A RESULT OF OLD-AGE [J].
ANDERSON, GW ;
EVEN, C ;
ROWLAND, RRR ;
PALMER, GA ;
HARTY, JT ;
PLAGEMANN, PGW .
JOURNAL OF NEUROVIROLOGY, 1995, 1 (3-4) :244-252
[2]   INFECTION OF CENTRAL-NERVOUS-SYSTEM CELLS BY ECOTROPIC MURINE LEUKEMIA-VIRUS IN C58 AND AKR MICE AND IN IN UTERO-INFECTED CE/J MICE PREDISPOSES MICE TO PARALYTIC INFECTION BY LACTATE DEHYDROGENASE-ELEVATING VIRUS [J].
ANDERSON, GW ;
PALMER, GA ;
ROWLAND, RRR ;
EVEN, C ;
PLAGEMANN, PGW .
JOURNAL OF VIROLOGY, 1995, 69 (01) :308-319
[3]   LACTATE DEHYDROGENASE-ELEVATING VIRUS ENTRY INTO THE CENTRAL-NERVOUS-SYSTEM AND REPLICATION IN ANTERIOR HORN NEURONS [J].
ANDERSON, GW ;
PALMER, GA ;
ROWLAND, RRR ;
EVEN, C ;
PLAGEMANN, PGW .
JOURNAL OF GENERAL VIROLOGY, 1995, 76 :581-592
[4]   DETECTION OF VIRAL-SPECIFIC NUCLEIC-ACID AND INTRACELLULAR VIRIONS IN VENTRAL HORN NEURONS OF LACTATE DEHYDROGENASE-ELEVATING VIRUS-INFECTED C58 MICE [J].
BRINTON, MA ;
GAVIN, EI ;
WEIBEL, J .
MICROBIAL PATHOGENESIS, 1986, 1 (06) :595-602
[5]   STRUCTURE AND CHEMICAL-PHYSICAL CHARACTERISTICS OF LACTATE DEHYDROGENASE-ELEVATING VIRUS AND ITS RNA [J].
BRINTONDARNELL, M ;
PLAGEMANN, PGW .
JOURNAL OF VIROLOGY, 1975, 16 (02) :420-433
[6]   ANTIBODY-RESPONSE OF MICE TO LACTATE DEHYDROGENASE-ELEVATING VIRUS DURING INFECTION AND IMMUNIZATION WITH INACTIVATED VIRUS [J].
CAFRUNY, WA ;
CHAN, SPK ;
HARTY, JT ;
YOUSEFI, S ;
KOWALCHYK, K ;
MCDONALD, D ;
FOREMAN, B ;
BUDWEG, G ;
PLAGEMANN, PGW .
VIRUS RESEARCH, 1986, 5 (04) :357-375
[7]   Inhibition of virus-induced age-dependent poliomyelitis by interferon-gamma [J].
Cafruny, WA ;
Haven, TR ;
Lawson, SR ;
Wong, GHW ;
Rowland, RRR .
ANTIVIRAL RESEARCH, 1997, 36 (01) :1-9
[8]  
CHEN Z, 1998, IN PRESS J NEUROVIRO
[9]   Detection of lactate dehydrogenase-elevating virus in transplantable mouse tumors by biological assay and RT-PCR assays and its removal from the tumor cell [J].
Chen, ZY ;
Plagemann, PGW .
JOURNAL OF VIROLOGICAL METHODS, 1997, 65 (02) :227-236
[10]   Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection [J].
Chen, ZY ;
Rowland, RRR ;
Anderson, GW ;
Palmer, GA ;
Plagemann, PGW .
JOURNAL OF VIROLOGY, 1997, 71 (04) :2913-2920